<p>[si&shy;ze=130]<span style="text-decoration: underline;">Steck&shy;brie&shy;f: Mil&shy;naci&shy;pran (I&shy;<span class="caps">XEL</span>&amp;reg;)</span>[/&shy;si&shy;ze]</p>
<p><strong>Mil&shy;naci&shy;pran</strong> ist ein An&shy;ti&shy;de&shy;pres&shy;si&shy;vum aus der Grup&shy;pe&nbsp;der <a href="http://adfd.org/wissen/Serotonin-Noradrenalin-Wiederaufnahmehemmer">Se&shy;ro&shy;to&shy;nin-No&shy;rad&shy;rena&shy;lin-Wie&shy;der&shy;auf&shy;nah&shy;me&shy;hem&shy;mer</a> (S&shy;N&shy;<span class="caps">RI</span>). Es wur&shy;de in&shy;ner&shy;halb der <span class="caps">EU</span> zu&shy;erst in Ös&shy;ter&shy;reich zu&shy;ge&shy;las&shy;sen und ist in Deutsch&shy;land und der Schweiz nicht er&shy;hält&shy;lich (Stand Ju&shy;li 2007). Von&nbsp;der <em>che&shy;mi&shy;schen&nbsp;Struk&shy;tur</em> her han&shy;delt es sich bei der Sub&shy;stanz um einen Ab&shy;kömm&shy;ling (De&shy;ri&shy;vat)&nbsp;des <em>Phe&shy;ny&shy;le&shy;thylamin</em>s (<span class="caps">PEA</span>), ähn&shy;lich&nbsp;den <a href="http://www.adfd.org/forum/viewtopic.php?t=1721">Am&shy;fe&shy;ta&shy;mi&shy;nen</a>.</p>
<p><strong><em><a href="http://www.elisanet.fi/antirepressivum/ad-amf/milnacipran.png">Che&shy;mi&shy;sche Struk&shy;tur von&nbsp;Mil&shy;naci&shy;pran</a></em></strong></p>
<p>[si&shy;ze=120]<span style="text-decoration: underline;">Che&shy;mi&shy;sche&nbsp;Ei&shy;gen&shy;schaf&shy;ten</span>[/&shy;si&shy;ze]</p>
<p><strong><em><a href="http://de.wikipedia.org/wiki/Milnacipran">- sie&shy;he Wi&shy;ki&shy;pe&shy;dia&nbsp;-</a></em></strong></p>
<p>[si&shy;ze=120]<span style="text-decoration: underline;">Phar&shy;ma&shy;ko&shy;lo&shy;gie</span>[/&shy;si&shy;ze]</p>
<p>Mil&shy;naci&shy;pran hemmt im Zen&shy;tral&shy;ner&shy;ven&shy;sys&shy;tem die Wie&shy;der&shy;auf&shy;nah&shy;me&nbsp;(das <em>Re-Upt&shy;a&shy;ke</em>) von Se&shy;ro&shy;to&shy;nin und No&shy;rad&shy;rena&shy;lin aus dem syn&shy;ap&shy;ti&shy;schen Spalt in die prä&shy;syn&shy;ap&shy;ti&shy;schen Ve&shy;si&shy;kel. Ver&shy;gleich&shy;ba&shy;re Me&shy;cha&shy;nis&shy;men wur&shy;den bei vie&shy;len an&shy;de&shy;ren An&shy;ti&shy;de&shy;pres&shy;si&shy;va fest&shy;ge&shy;stell&shy;t. Ein stim&shy;mungs&shy;auf&shy;hel&shy;len&shy;der Ef&shy;fekt von Mil&shy;naci&shy;pran könn&shy;te auf ähn&shy;li&shy;chen mo&shy;le&shy;ku&shy;la&shy;ren Vor&shy;gän&shy;gen ba&shy;sie&shy;ren wie die Wir&shy;kun&shy;gen von <span class="caps">SS</span>&shy;<span class="caps">RI</span> und <span class="caps">SN</span>&shy;<span class="caps">RI</span>.</p>
<p>Die Sub&shy;stanz soll nicht mit Ad&shy;re&shy;no&shy;zep&shy;to&shy;ren oder hi&shy;sta&shy;mi&shy;ner&shy;gen H1-Re&shy;zep&shy;to&shy;ren wech&shy;sel&shy;wir&shy;ken und nur ei&shy;ne sehr ge&shy;rin&shy;ge Af&shy;fi&shy;ni&shy;tät zu cho&shy;li&shy;ner&shy;gen, Ben&shy;zo&shy;dia&shy;ze&shy;pin-, Opiat- oder do&shy;pa&shy;mi&shy;ner&shy;gen D1-/D2-Re&shy;zep&shy;to&shy;ren be&shy;sit&shy;zen. Es gibt den&shy;noch kla&shy;re An&shy;halts&shy;punk&shy;te da&shy;für, dass Mil&shy;naci&shy;pran - wie die Am&shy;fe&shy;ta&shy;mi&shy;ne - auch mit dem do&shy;pa&shy;mi&shy;ner&shy;gen Sys&shy;tem in&shy;ter&shy;fe&shy;riert&nbsp;(<strong>1</strong>), was mit der che&shy;mi&shy;schen Ver&shy;wandt&shy;schaft zum <span class="caps">PEA</span> plau&shy;si&shy;bel er&shy;klärt wer&shy;den&nbsp;könn&shy;te.</p>
<p>[si&shy;ze=120]<span style="text-decoration: underline;">In&shy;di&shy;ka&shy;tio&shy;nen</span>[/&shy;si&shy;ze]</p>
<p>Mil&shy;naci&shy;pran kann in den Staa&shy;ten, wo ei&shy;ne Zu&shy;las&shy;sung als Arz&shy;nei&shy;mit&shy;tel be&shy;steht, zur Be&shy;hand&shy;lung von De&shy;pres&shy;sio&shy;nen bei Er&shy;wach&shy;se&shy;nen an&shy;ge&shy;wen&shy;det&nbsp;wer&shy;den.</p>
<p>[si&shy;ze=120]<span style="text-decoration: underline;">Kon&shy;train&shy;di&shy;ka&shy;tio&shy;nen</span>[/&shy;si&shy;ze]</p>
<p>Bei Kin&shy;dern und Ju&shy;gend&shy;li&shy;chen ist die&nbsp;An&shy;wen&shy;dung <strong>kon&shy;train&shy;di&shy;ziert</strong>. Die für <span class="caps">SS</span>&shy;<span class="caps">RI</span> und <span class="caps">SN</span>&shy;<span class="caps">RI</span> er&shy;gan&shy;ge&shy;ne of&shy;fi&shy;zi&shy;el&shy;le War&shy;nung der <span class="caps">EU</span>-Arz&shy;nei&shy;mit&shy;tel&shy;be&shy;hör&shy;de <span class="caps">EMEA</span> gilt eben&shy;so für Mil&shy;naci&shy;pran&nbsp;(<strong>2</strong>).</p>
<p>Dar&shy;über hi&shy;n&shy;aus ist die gleich&shy;zei&shy;ti&shy;ge Ver&shy;ab&shy;rei&shy;chung von <span class="caps">MAO</span>-&shy;Hem&shy;mern und Ka&shy;techo&shy;la&shy;mi&shy;nen (Ad&shy;rena&shy;lin, No&shy;rad&shy;rena&shy;lin, Do&shy;pa&shy;min; so&shy;wie prin&shy;zi&shy;pi&shy;ell Se&shy;ro&shy;to&shy;nin und -vor&shy;stu&shy;fen) strikt zu un&shy;ter&shy;las&shy;sen, da die Ge&shy;fahr&nbsp;ei&shy;nes <a href="http://adfd.org/wissen/Serotonin-Syndrom">Se&shy;ro&shy;to&shy;nin-&shy;Syn&shy;drom</a>s&nbsp;be&shy;steht.</p>
<p>[si&shy;ze=120]<span style="text-decoration: underline;">Wir&shy;kun&shy;gen</span>[/&shy;si&shy;ze]</p>
<p>Er&shy;wünsch&shy;te und un&shy;er&shy;wünsch&shy;te Wir&shy;kun&shy;gen äh&shy;neln den&shy;je&shy;ni&shy;gen an&shy;de&shy;rer <span class="caps">SS</span>&shy;<span class="caps">RI</span>/S&shy;N&shy;<span class="caps">RI</span>. Mit ähn&shy;li&shy;cher Ent&shy;zugs&shy;pro&shy;ble&shy;ma&shy;tik wie et&shy;wa vom Ven&shy;lafa&shy;xin (T&shy;<span class="caps">RE</span>&shy;<span class="caps">VI</span>&shy;<span class="caps">LOR</span>, <span class="caps">EFE</span>&shy;X&shy;<span class="caps">OR</span>) be&shy;kannt ist zu&nbsp;rech&shy;nen.</p>
<p>[si&shy;ze=120]<span style="text-decoration: underline;">Stel&shy;len&shy;wert und&nbsp;Ver&shy;füg&shy;bar&shy;keit</span>[/&shy;si&shy;ze]</p>
<p>Mil&shy;naci&shy;pran&nbsp;gilt <strong>nicht</strong> als Erst&shy;wahl&shy;mit&shy;tel zur Be&shy;hand&shy;lung der De&shy;pres&shy;sion, da bes&shy;ser er&shy;prob&shy;te Sub&shy;stan&shy;zen in aus&shy;rei&shy;chen&shy;der Zahl zur Ver&shy;fü&shy;gung&nbsp;ste&shy;hen.</p>
<p>[si&shy;ze=110]<span style="text-decoration: underline;">Be&shy;wer&shy;tung der an&shy;ti&shy;de&shy;pres&shy;si&shy;ven&nbsp;Wir&shy;kung</span>[/&shy;si&shy;ze]</p>
<p>Laut&nbsp;ei&shy;nem <strong><em>Cochra&shy;ne-Re&shy;view</em></strong> vom Ok&shy;to&shy;ber 2005 wirkt Mil&shy;naci&shy;pran et&shy;was schwä&shy;cher als Fluo&shy;xe&shy;tin ge&shy;gen de&shy;pres&shy;si&shy;ve Sym&shy;pto&shy;me&nbsp;(<strong>3</strong>).</p>
<p>[si&shy;ze=110]<span style="text-decoration: underline;">Eta&shy;blie&shy;rung auf dem&nbsp;Arz&shy;nei&shy;mit&shy;tel&shy;markt</span>[/&shy;si&shy;ze]</p>
<p>Mil&shy;naci&shy;pran konn&shy;te seit der Er&shy;stein&shy;füh&shy;rung in Ös&shy;ter&shy;reich 1998 kei&shy;nen be&shy;deu&shy;ten&shy;den Markt&shy;an&shy;teil er&shy;rin&shy;gen. Her&shy;stel&shy;ler und Ver&shy;trei&shy;ber ver&shy;zich&shy;te&shy;ten in der Fol&shy;ge auf den Marktein&shy;tritt in wei&shy;te&shy;ren <span class="caps">EU</span>-&shy;Staa&shy;ten, ob&shy;wohl die Zu&shy;las&shy;sung in ei&shy;nem Mit&shy;glieds&shy;land der Ge&shy;mein&shy;schaft prin&shy;zi&shy;pi&shy;ell die Ver&shy;kehrs&shy;fä&shy;hig&shy;keit im ge&shy;sam&shy;ten <span class="caps">EU</span>-Raum&nbsp;be&shy;wirk&shy;t.</p>
<p>In ei&shy;nem &quot;zwei&shy;ten An&shy;lauf&quot; be&shy;rei&shy;ten fi&shy;nanz- und mar&shy;ke&shy;ting&shy;star&shy;ke Part&shy;ner seit et&shy;wa 2004 die brei&shy;te Marktein&shy;füh&shy;rung in den <span class="caps">USA</span> vor. Laut Bör&shy;sen&shy;be&shy;rich&shy;ten ha&shy;ben In&shy;ves&shy;to&shy;ren meh&shy;re&shy;re 100 Mil&shy;lio&shy;nen Dol&shy;lar be&shy;reit&shy;ge&shy;stell&shy;t, um die <span class="caps">US</span>-&shy;Zu&shy;las&shy;sung von Mil&shy;naci&shy;pran für die In&shy;di&shy;ka&shy;ti&shy;on Fi&shy;bro&shy;my&shy;al&shy;gie-&shy;Syn&shy;drom (<span class="caps">FMS</span>) zu er&shy;rei&shy;chen&nbsp;(<strong>4</strong>). Für die&shy;se um&shy;strit&shy;te&shy;ne Dia&shy;gno&shy;se exis&shy;tiert in den <span class="caps">USA</span> bis&shy;lang kein zu&shy;ge&shy;las&shy;se&shy;nes&nbsp;Me&shy;di&shy;ka&shy;ment.</p>
<p>Die Ein&shy;füh&shy;rung in Ös&shy;ter&shy;reich ging sei&shy;ner&shy;zeit u.a. mit &quot;unsau&shy;be&shy;ren&quot; Prak&shy;ti&shy;ken ein&shy;her&nbsp;(<strong>5</strong>). Ähn&shy;li&shy;ches kann we&shy;gen&nbsp;des <strong>Di&shy;sea&shy;se&nbsp;Mon&shy;ge&shy;ring</strong>(*) rund um <span class="caps">FMS</span> für den <span class="caps">US</span>-&shy;Markt ver&shy;mu&shy;tet&nbsp;wer&shy;den.</p>
<p>[si&shy;ze=120]<span style="text-decoration: underline;">Han&shy;delsprä&shy;pa&shy;ra&shy;te</span>[/&shy;si&shy;ze]</p>
<p>Der Mar&shy;ken&shy;na&shy;me des in Ös&shy;ter&shy;reich ver&shy;trie&shy;be&shy;nen Mil&shy;naci&shy;pran-Prä&shy;pa&shy;rats&nbsp;ist <strong><em><span class="caps">IXEL</span>®</em></strong> (Hart&shy;kap&shy;seln). Die Do&shy;sis be&shy;trägt da&shy;bei 50 mg Mil&shy;naci&shy;pran je Kap&shy;sel zur zwei&shy;ma&shy;li&shy;gen täg&shy;li&shy;chen Ein&shy;nah&shy;me (100&nbsp;mg/&shy;Tag).</p>
<p>Mil&shy;naci&shy;pran war welt&shy;weit et&shy;wa zur Jah&shy;res&shy;mit&shy;te 2005 in 32 Staa&shy;ten er&shy;hält&shy;lich. In der Schweiz und in Deutsch&shy;land be&shy;stand - man&shy;gels An&shy;trag des Her&shy;stel&shy;lers - auch per Ju&shy;li 2007 kei&shy;ne Zu&shy;las&shy;sung, ob&shy;wohl die deut&shy;sche Ge&shy;neh&shy;mi&shy;gung mit&shy;tels ei&shy;nes Ver&shy;wal&shy;tungs&shy;akts er&shy;teilt wer&shy;den&nbsp;könn&shy;te.</p>
<p>[si&shy;ze=130]<span style="text-decoration: underline;">Re&shy;fe&shy;ren&shy;zen</span>[/&shy;si&shy;ze]</p>
<p>*(<strong>1</strong>) <em><a href="http://tinyurl.com/yo4fjr">Ef&shy;fect of re&shy;pea&shy;ted treat&shy;ment with mil&shy;naci&shy;pran on the cen&shy;tral do&shy;pa&shy;mi&shy;ner&shy;gic&nbsp;sys&shy;tem.</a></em> Pol J Phar&shy;ma&shy;col. 2000&nbsp;Mar-A&shy;pr;52(2):83-92.
*(<strong>2</strong>) <a href="http://www.bfarm.de/de/vigilanz/am_sicher_akt/index.php?pv=&amp;more=antidepressiva.php">Pres&shy;se&shy;mit&shy;tei&shy;lung</a> der <a href="http://www.emea.eu.int"><span class="caps">EMEA</span></a> in deut&shy;scher Über&shy;set&shy;zung&nbsp;des <a href="http://www.bfarm.de">BfArM</a>
*(<strong>3</strong>) <em><a href="http://tinyurl.com/2y2nwu">Fluo&shy;xe&shy;ti&shy;ne ver&shy;sus other ty&shy;pes of phar&shy;ma&shy;co&shy;the&shy;ra&shy;py for&nbsp;de&shy;pres&shy;si&shy;on.</a></em> Cochra&shy;ne Da&shy;ta&shy;ba&shy;se Syst Re&shy;v. 2005 Oct 19;(4):<span class="caps">CD004185</span>.
*(<strong>4</strong>) <em><a href="http://web.consors.de/CatFront/JspNews.jsp?m_id=629663">Cy&shy;press Bio er&shy;hält Mil&shy;lio&shy;nen&shy;vor&shy;schuss für&nbsp;Me&shy;di&shy;ka&shy;ment.</a></em> (con&shy;sor&shy;s/&shy;fi&shy;nan&shy;zen.&shy;net)
*(<strong>5</strong>) <em><a href="http://www.akdae.de/25/Archiv/200202.pdf">Was hat Schei&shy;ben&shy;brot mit An&shy;ti&shy;de&shy;pres&shy;si&shy;va zu&nbsp;tun?</a></em> - Zu&shy;schrift&nbsp;in <em>Arz&shy;nei&shy;ver&shy;ord&shy;nung in der&nbsp;Pra&shy;xis</em>, hrs&shy;g. von&nbsp;der <a href="http://www.akdae.de/"><span class="caps">AK</span>&shy;dÄ</a>,&nbsp;2/2002.</p>
<p>[si&shy;ze=120]<span style="text-decoration: underline;">We&shy;b&shy;links</span>[/&shy;si&shy;ze]</p>
<p><a href="http://www.ixel.at/fachinfo.html">Fach&shy;in&shy;for&shy;ma&shy;ti&shy;on zu <span class="caps">IXEL</span>®</a> auf <a href="http://www.ixel.at/"><span class="caps">IXEL</span>.at</a></p>
<p>[si&shy;ze=120]<span style="text-decoration: underline;">An&shy;mer&shy;kun&shy;gen</span>[/&shy;si&shy;ze]</p>
<p>*(*) <strong><em>Di&shy;sea&shy;se&nbsp;Mon&shy;ge&shy;ring</em></strong> heißt so&shy;viel wie &quot;Han&shy;deln mit Krank&shy;hei&shy;ten&quot;. Hier&shy;mit ist die pro&shy;fit&shy;träch&shy;ti&shy;ge Vor&shy;ge&shy;hens&shy;wei&shy;se der Phar&shy;ma&shy;in&shy;dus&shy;trie ge&shy;meint, Krank&shy;hei&shy;ten oder an&shy;geb&shy;lich krank&shy;haf&shy;te Zu&shy;stän&shy;de in der Öf&shy;fent&shy;lich&shy;keit zu pro&shy;pa&shy;gie&shy;ren, um an&shy;schlie&shy;ßend die &quot;pas&shy;sen&shy;den&quot; Arz&shy;nei&shy;mit&shy;tel ver&shy;kau&shy;fen zu&nbsp;kön&shy;nen.</p>
<p>*Die&shy;ser Ar&shy;ti&shy;kel wur&shy;de ur&shy;sprüng&shy;lich&nbsp;für <a href="http://de.wikipedia.org/wiki/Milnacipran">Wi&shy;ki&shy;pe&shy;dia</a> er&shy;stell&shy;t. Die Ur&shy;he&shy;ber&shy;rech&shy;te lie&shy;gen beim Au&shy;tor, dar&shy;um ist die Ver&shy;ar&shy;bei&shy;tung hier oh&shy;ne Ver&shy;weis auf&nbsp;die <a href="http://de.wikipedia.org/wiki/GNU-FDL"><span class="caps">GNU</span>-<span class="caps">FDL</span></a> recht&shy;mäs&shy;sig. Je&shy;de Ver&shy;wen&shy;dung die&shy;ser In&shy;hal&shy;te au&shy;ßer&shy;halb des <span class="caps">ADFD</span> darf nur ge&shy;mä&shy;ss der Be&shy;nut&shy;zer&shy;richt&shy;li&shy;ni&shy;en von <span class="caps">ADF</span>&shy;D.wis&shy;sen&nbsp;er&shy;fol&shy;gen.</p>
<p><a href="http://adfd.org/wissen/Category:Medikament">Ca&shy;te&shy;go&shy;ry:&shy;Me&shy;di&shy;ka&shy;ment</a></p>
<p>im&shy;por&shy;tiert aus <span class="caps">ADF</span>&shy;D.wis&shy;sen</p>
<p>Au&shy;tor:&nbsp;PhilRS
Erst&shy;ver&shy;öf&shy;fent&shy;li&shy;chung:&nbsp;10.6.2007 
Let&shy;ze Be&shy;ar&shy;bei&shy;tung:&nbsp;10.6.2007</p>